SeaStar Medical (ICU) and Its Peers Financial Contrast

SeaStar Medical (NASDAQ:ICU) is one of 454 publicly-traded companies in the “Biotechnology” industry, but how does it contrast to its rivals? We will compare SeaStar Medical to similar companies based on the strength of its valuation, profitability, institutional ownership, analyst recommendations, earnings, risk and dividends.

Analyst Ratings

This is a summary of recent ratings and recommmendations for SeaStar Medical and its rivals, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SeaStar Medical	0	0	0	0	N/A
SeaStar Medical Competitors	667	2445	6355	97	2.62

As a group, “Biotechnology” companies have a potential upside of 108.97%. Given SeaStar Medical’s rivals higher possible upside, analysts clearly believe SeaStar Medical has less favorable growth aspects than its rivals.

Volatility and Risk

SeaStar Medical has a beta of -1.18, suggesting that its share price is 218% less volatile than the S&P 500. Comparatively, SeaStar Medical’s rivals have a beta of 1.18, suggesting that their average share price is 18% more volatile than the S&P 500.

Insider & Institutional Ownership

1.7% of SeaStar Medical shares are owned by institutional investors. Comparatively, 30.5% of shares of all “Biotechnology” companies are owned by institutional investors. 4.5% of SeaStar Medical shares are owned by company insiders. Comparatively, 21.3% of shares of all “Biotechnology” companies are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Earnings & Valuation

This table compares SeaStar Medical and its rivals revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
SeaStar Medical	N/A	-$26.23 million	-0.36
SeaStar Medical Competitors	$214.36 million	$13.74 million	-69.85

SeaStar Medical’s rivals have higher revenue and earnings than SeaStar Medical. SeaStar Medical is trading at a higher price-to-earnings ratio than its rivals, indicating that it is currently more expensive than other companies in its industry.

Profitability

This table compares SeaStar Medical and its rivals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
SeaStar Medical	N/A	N/A	-741.57%
SeaStar Medical Competitors	-8,301.93%	-131.62%	-25.63%

Summary

SeaStar Medical rivals beat SeaStar Medical on 7 of the 10 factors compared.

SeaStar Medical Company Profile

SeaStar Medical Holding Corporation, a medical device company, develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers inflammatory response to fend off infections and repair damaged tissue in the body. It is also developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome. The company is headquartered in Denver, Colorado.